REAMBERIN

Active material: meglumin sodium succinate
When ATH: B05BB
CCF: The drug is a detoxification effect for parenteral use
ICD-10 codes (testimony): R54, Z51.8
When CSF: 21.06
Manufacturer: POLYSAN NTFF Ltd. (Russia)

Pharmaceutical form, composition and packaging

Solution for infusion 1.5% clear, colorless.

Excipients: sodium chloride, potassium chloride, magnesium chloride, Sodium hydroxide, water d / and.

100 ml – Bottles (1) – packs cardboard.
200 ml – Bottles (1) – packs cardboard.
400 ml – Bottles (1) – packs cardboard.

Pharmacological action

The drug is a detoxification effect for parenteral use. It has anti-inflammatory and antioxidant action, exerting a positive effect on aerobic processes in the cell, reducing the production of free radicals and restoring the energy potential of the cells.

The drug activates enzymatic processes the Krebs cycle and promotes utilization of fatty acids and glucose into cells, normalizes acid-base balance and blood gases. It has a mild diuretic effect.

Pharmacokinetics

The on / in the introduction of the drug can be utilized in quickly and does not accumulate in the body.

Testimony

- As a means of detoxification and antihypoxic acute endogenous and exogenous intoxications of different etiology in adults and children older 1 g.

Dosage regimen

Adults Reamʙerin^® introduced into / in the drip at a rate of no more than 90 drop / min. (1-4.5 ml / min) in volume 400-800 ml / day.

The rate of administration and dosage is determined according to the degree of severity of the disease of the patient.

Children under the age of 1 year Reamʙerin^® injected / drip rate of 6-10 ml / kg body weight 1 times / day with a velocity 3-4 ml / min. The daily dose should not exceed 400 ml.

Course duration of administration should not exceed 11 days.

Side effect

Maybe: the rapid introduction of the drug momentary feeling the heat, reddening of the upper body.

Contraindications

- State after traumatic brain injury, accompanied by a swelling of the brain;

- Expressed by the human kidney;

- Pregnancy;

- Lactation (breast-feeding);

- Hypersensitivity to the drug.

FROM caution drug should be used during alkalosis.

Pregnancy and lactation

The drug is contraindicated during pregnancy and lactation.

Cautions

Against the background of Reamberin^® may cause an alkaline reaction of blood and urine (because activation aerobic processes in the body).

Overdose

Data on drug overdose Reamberin^® not provided.

Drug Interactions

The drug can be used in combination with antibiotics, water-soluble vitamins and glucose solution.

Conditions of supply of pharmacies

The drug is released under the prescription.

Conditions and terms

The drug should be stored out of reach of children, dark place at a temperature from 0 ° to 25 ° C; Avoid freezing. Shelf life – 5 years.

If you change the color of the solution or the presence of sediment drug application inadmissible.